의료용품(ko) › Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses or in forms or(en)
其他麻醉劑
HS 300490中國 → 臺灣
1概覽
- 目的地關稅: 0% (第一欄, 30049010107) — 與中國無優惠協定,適用基本/最惠國稅率。
- 營業稅: 5%
- 此號列涵蓋: 其他麻醉劑
- 須留意的制度: Taiwan express low-value exemption and frequency capExpress consignments up to NT$2,000 are duty free, but a consignee exceeding six such entries in a half-year loses the exemption and moves to formal declaration.web.customs.gov.tw
重點
- 小額免稅:同批貨物完稅價格新臺幣 2,000 元以下免徵關稅、營業稅與貨物稅;同一納稅義務人半年度內逾 6 次者列為頻繁進口,不再適用。
- 營業稅 5%,由海關代徵;另有推廣貿易服務費 0.04%、貨物稅(限法定項目)與菸酒稅。
- 委任報關業者非強制,納稅義務人可自行報關,但仍須透過關港貿單一窗口以電子方式申報。
- 快遞貨物依完稅價格分為 X1(文件)、X2(2,000 元以下免稅)、X3(2,001 至 50,000 元應稅)、X4(逾 50,000 元,須以一般進口報單申報)。
- 自中國大陸進口前,務必查詢貨品分類表「輸入規定」欄是否列有 MW0 或 MP1。
資料日期: 2026-07-29
2稅則分類
HS6 品名
- ko기타
- enOther anesthetics
- zh_hant其他麻醉劑
- zh_hans其他麻醉剂
臺灣 稅則號列
| 號列 | 品名 |
|---|---|
| 30049010107 | 醫藥製劑,含有硫美妥者(包括異構物、酯類、醚類及鹽類)Medicaments,containing thiamylal,5-allyl-5-(1-methylbutyl)-2-thiobarbiturates, including: Isomers, Esters, Ethers, Salts |
| 30049010205 | 醫藥製劑,含有愷他命及其異構物、酯類、醚類及鹽類者Medicaments, containing Ketamine , and its isomer, esters, ethers, salts |
| 30049010303 | 醫藥製劑,含有丙泊酚、依托咪酯,及其異構物、酯類、醚類及鹽類者Medicaments, containing Propofol , Etomidate, and their isomer, esters, ethers, salts |
| 30049010900 | 其他麻醉劑Other anesthetics |
| 30049020007 | 血液代用品與血漿代用品及基因重組製劑Substitutes of blood, substitutes of plasma and preparations of gennetic recombinants |
| 30049030005 | 營養與電解質液Nutrients and electrolytes |
| 30049040003 | 洗腎用清洗液,具有劑量或零售包裝式樣者Hemodialysis concentrate, put up in measured doses or in forms or packings for retail sale |
| 30049050000 | 磺胺藥Antibacterial, sulfa drugs |
| 30049061007 | 中藥酒劑Chinese medicine wine |
| 30049069009 | 其他中藥製劑Other chinese medicine preparations |
| 30049071005 | 抗癌藥Anti-cancer preparations |
| 30049072004 | 抗人類免疫缺乏病毒感染用藥Drugs for anti human immunodeficiency virus (HIV) infections |
| 30049080004 | 農藥中毒解毒劑Pesticide-poisoning cures |
| 30049091001 | 抗排斥醫藥製劑Immunosuppressive preparations |
| 30049092000 | 安瓿裝蒸餾水Water, distilled, in ampoules |
| 30049099101 | 抗過敏抗組織胺用藥Drugs for antihypersensitivity and antihistamine |
| 30049099218 | 醫藥製劑,含有西可巴比妥者Medicaments, containing secobarbital |
| 30049099227 | 醫藥製劑,含有異戊巴比妥者Medicaments, containing amobarbital |
| 30049099316 | 醫藥製劑,含有三唑他(三唑侖)者Medicaments, containing Triazolam |
| 30049099325 | 醫藥製劑,含有氟硝西泮者Medicaments, containing Flunitrazepam |
| 30049099334 | 醫藥製劑,含有氯甲西泮(甲基樂耐平)者Medicaments, containing Lormetazepam |
| 30049099343 | 醫藥製劑,含有氟地西泮(氟二氮平)者Medicaments, containing Fludiazepam |
| 30049099352 | 醫藥製劑,含有舒樂安定(伊疊唑侖)者Medicaments, containing Estazolam |
| 30049099361 | 醫藥製劑,含有阿普唑他(三氮二氮平)者Medicaments, containing Alprazolam |
| 30049099370 | 醫藥製劑,含有替馬西泮(甲羥氮平)者Medicaments, containing Temazepam |
| 30049099389 | 醫藥製劑,含有咪達唑他(咪氟唑侖)者Medicaments, containing Midazolam |
| 30049099414 | 醫藥製劑,含有特拉嗎竇者Medicaments, containing Tramadol |
| 30049099423 | 醫藥製劑,含有伯替唑他者Medicaments, containing Brotizolam |
| 30049099432 | 醫藥製劑,含有唑匹可隆者Medicaments, containing Zopiclone |
| 30049099441 | 玻璃體替代物Viscoelastic material for ophthalmic surgery |
| 30049099450 | 醫藥製劑,含有札來普隆者Medicaments, containing Zaleplon |
| 30049099469 | 醫藥製劑,含有佐沛眠者Medicaments, containing Zolpidem |
| 30049099520 | 醫藥製劑,含有瑞吩坦尼及其異構物、酯類、醚類及鹽類者Medicaments, containing Remifentanil, and its isomer, esters, ethers, salts |
| 30049099539 | 醫藥製劑,含有阿華吩坦尼及其異構物、酯類、醚類及鹽類者Medicaments, containing Alfentanyl , and its isomer, esters, ethers, salts |
| 30049099548 | 醫藥製劑,含有吩坦尼及其異構物、酯類、醚類及鹽類者Medicaments, containing Fentanyl , and its isomer, esters, ethers, salts |
| 30049099557 | 醫藥製劑,含有美沙冬及其異構物、酯類、醚類及鹽類者Medicaments, containing Methadone , and its isomer, esters, ethers, salts |
| 30049099566 | 醫藥製劑,含有潘他唑新及其異構物、酯類、醚類及鹽類者Medicaments, containing Pentazocine , and its isomer, esters, ethers, salts |
| 30049099575 | 醫藥製劑,含有蘇吩坦尼及其異構物、酯類、醚類及鹽類者Medicaments, containing Sufentanil , and its isomer, esters, ethers, salts |
| 30049099584 | 醫藥製劑,含有四氫大麻酚及其異構物、酯類、醚類及鹽類者Medicaments, containing Tetrahydrocannabinols, and its isomer, esters, ethers, salts |
| 30049099593 | 醫藥製劑,含有派醋甲酯及其異構物、酯類、醚類及鹽類者Medicaments, containing Methylphenidate , and its isomer, esters, ethers, salts |
| 30049099619 | 醫藥製劑,含有他噴他竇及其異構物、酯類、醚類及鹽類者Medicaments, containing Tapentadol, and its isomers, esters, ethers, salts |
| 30049099628 | 醫藥製劑,含有戊巴比妥(不含異戊巴比妥)及其異構物、酯類、醚類及鹽類者Medicaments, containing Pentobarbital(excluding amobarbital), and its isomer, esters, ethers, salts |
| 30049099637 | 醫藥製劑,含有硝甲西泮(硝甲氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Nimetazepam , and its isomer, esters, ethers, salts |
| 30049099646 | 醫藥製劑,含有巴比妥及其異構物、酯類、醚類及鹽類者Medicaments, containing Barbital , and its isomer, esters, ethers, salts |
| 30049099655 | 醫藥製劑,含有溴西泮(溴氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Bromazepam , and its isomer, esters, ethers, salts |
| 30049099664 | 醫藥製劑,含有勞拉西泮(樂耐平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Lorazepam , and its isomer, esters, ethers, salts |
| 30049099673 | 醫藥製劑,含有美達西泮(美達氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Medazepam , and its isomer, esters, ethers, salts |
| 30049099682 | 醫藥製劑,含有甲丙氨酯(美普巴邁)及其異構物、酯類、醚類及鹽類者Medicaments, containing Meprobamate , and its isomer, esters, ethers, salts |
| 30049099691 | 醫藥製劑,含有硝西泮(耐妥眠)及其異構物、酯類、醚類及鹽類者Medicaments, containing Nitrazepam , and its isomer, esters, ethers, salts |
| 30049099717 | 醫藥製劑,含有去甲西泮(原氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Nordazepam , and its isomer, esters, ethers, salts |
| 30049099726 | 醫藥製劑,含有去甲羥安定(歐沙氮平、去甲羥氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Oxazepam , and its isomer, esters, ethers, salts |
| 30049099735 | 醫藥製劑,含有噁唑他(㗁甲唑侖)及其異構物、酯類、醚類及鹽類者Medicaments, containing Oxazolam , and its isomer, esters, ethers, salts |
| 30049099744 | 醫藥製劑,含有匹嗎啉(苯㗁唑啉)及其異構物、酯類、醚類及鹽類者Medicaments, containing Pemoline , and its isomer, esters, ethers, salts |
| 30049099753 | 醫藥製劑,含有氯巴占(甲酮氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing clobazam , and its isomer, esters, ethers, salts |
| 30049099762 | 醫藥製劑,含有氯硝西泮(可那氮平、氯硝氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Clonazepam , and its isomer, esters, ethers, salts |
| 30049099771 | 醫藥製劑,含有氯拉䓬酸(氯氮平酸鹽)及其異構物、酯類、醚類及鹽類者Medicaments, containing Clorazepate , and its isomer, esters, ethers, salts |
| 30049099780 | 醫藥製劑,含有氯噁唑他(氯㗁唑侖)及其異構物、酯類、醚類及鹽類者Medicaments, containing Cloxazolam , and its isomer, esters, ethers, salts |
| 30049099799 | 醫藥製劑,含有安定(二氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Diazepam , and its isomer, esters, ethers, salts |
| 30049099815 | 醫藥製劑,含有氟安定(氟路洛)及其異構物、酯類、醚類及鹽類者Medicaments, containing Flurazepam , and its isomer, esters, ethers, salts |
| 30049099824 | 醫藥製劑,含有普拉西泮(環丙氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Prazepam , and its isomer, esters, ethers, salts |
| 30049099833 | 醫藥製劑,含有莫待芬寧及其異構物、酯類、醚類及鹽類者Medicaments, containing Modafinil , and its isomer, esters, ethers, salts |
| 30049099842 | 醫藥製劑,含有美妥芬諾及其異構物、酯類、醚類及鹽類者Medicaments, containing Butorphanol , and its isomer, esters, ethers, salts |
| 30049099851 | 醫藥製劑,含有氯苄雷司及其異構物、酯類、醚類及鹽類者Medicaments, containing Clobenzorex , and its isomer, esters, ethers, salts |
| 30049099860 | 醫藥製劑,含有離胺右旋安非他命及其異構物、酯類、醚類及鹽類者Medicaments, containing Lisdexamphetamine , and its isomer, esters, ethers, salts |
| 30049099904 | 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale |
中國 出口端號列(參考)
- 30049010---含有磺胺类
- 30049020---含有联苯双酯
- 30049051----中药酒
- 30049052----片仔癀
- 30049053----白药
- 30049054----清凉油
- 30049055----安宫牛黄丸
- 30049059----其他
- 30049090---其他
臺灣 案例前三筆
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者恢甲清覆甲液-全日型加強配方(未滅菌) EXCILOR FORTE-nail solution(non-sterile)
- 其他中藥製劑枳椇人參茶(Gan-Pyun-Han-Nal) / 液體茶 / 100ML /瓶
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者Hiruscar Silicone Pro(non-sterile) 喜療疤 疤痕護理矽凝膠(未滅菌)
資料日期: 2026-07-29
3關稅與稅金
與中國無優惠協定,適用基本/最惠國稅率。
| 號列 | 品名 | 第一欄 | 第二欄 | 第三欄 |
|---|---|---|---|---|
| 30049010107 | 醫藥製劑,含有硫美妥者(包括異構物、酯類、醚類及鹽類) | 0% | 0% | 0% |
| 30049010205 | 醫藥製劑,含有愷他命及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 0% |
| 30049010303 | 醫藥製劑,含有丙泊酚、依托咪酯,及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 0% |
| 30049010900 | 其他麻醉劑 | 0% | 0% | 0% |
| 30049020007 | 血液代用品與血漿代用品及基因重組製劑 | 0% | 0% | 0% |
| 30049030005 | 營養與電解質液 | 0% | 0% | 10% |
| 30049040003 | 洗腎用清洗液,具有劑量或零售包裝式樣者 | 0% | 0% | 10% |
| 30049050000 | 磺胺藥 | 0% | 0% | 20% |
| 30049061007 | 中藥酒劑 | 20% | 0% | 50% |
| 30049069009 | 其他中藥製劑 | 0% | 0% | 12.5% |
| 30049071005 | 抗癌藥 | 0% | 0% | 0% |
| 30049072004 | 抗人類免疫缺乏病毒感染用藥 | 0% | 0% | 10% |
| 30049080004 | 農藥中毒解毒劑 | 0% | 0% | 0% |
| 30049091001 | 抗排斥醫藥製劑 | 0% | 0% | 10% |
| 30049092000 | 安瓿裝蒸餾水 | 0% | 0% | 10% |
| 30049099101 | 抗過敏抗組織胺用藥 | 0% | 0% | 10% |
| 30049099218 | 醫藥製劑,含有西可巴比妥者 | 0% | 0% | 10% |
| 30049099227 | 醫藥製劑,含有異戊巴比妥者 | 0% | 0% | 10% |
| 30049099316 | 醫藥製劑,含有三唑他(三唑侖)者 | 0% | 0% | 10% |
| 30049099325 | 醫藥製劑,含有氟硝西泮者 | 0% | 0% | 10% |
| 30049099334 | 醫藥製劑,含有氯甲西泮(甲基樂耐平)者 | 0% | 0% | 10% |
| 30049099343 | 醫藥製劑,含有氟地西泮(氟二氮平)者 | 0% | 0% | 10% |
| 30049099352 | 醫藥製劑,含有舒樂安定(伊疊唑侖)者 | 0% | 0% | 10% |
| 30049099361 | 醫藥製劑,含有阿普唑他(三氮二氮平)者 | 0% | 0% | 10% |
| 30049099370 | 醫藥製劑,含有替馬西泮(甲羥氮平)者 | 0% | 0% | 10% |
| 30049099389 | 醫藥製劑,含有咪達唑他(咪氟唑侖)者 | 0% | 0% | 10% |
| 30049099414 | 醫藥製劑,含有特拉嗎竇者 | 0% | 0% | 10% |
| 30049099423 | 醫藥製劑,含有伯替唑他者 | 0% | 0% | 10% |
| 30049099432 | 醫藥製劑,含有唑匹可隆者 | 0% | 0% | 10% |
| 30049099441 | 玻璃體替代物 | 0% | 0% | 10% |
| 30049099450 | 醫藥製劑,含有札來普隆者 | 0% | 0% | 10% |
| 30049099469 | 醫藥製劑,含有佐沛眠者 | 0% | 0% | 10% |
| 30049099520 | 醫藥製劑,含有瑞吩坦尼及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099539 | 醫藥製劑,含有阿華吩坦尼及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099548 | 醫藥製劑,含有吩坦尼及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099557 | 醫藥製劑,含有美沙冬及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099566 | 醫藥製劑,含有潘他唑新及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099575 | 醫藥製劑,含有蘇吩坦尼及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099584 | 醫藥製劑,含有四氫大麻酚及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099593 | 醫藥製劑,含有派醋甲酯及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099619 | 醫藥製劑,含有他噴他竇及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099628 | 醫藥製劑,含有戊巴比妥(不含異戊巴比妥)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099637 | 醫藥製劑,含有硝甲西泮(硝甲氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099646 | 醫藥製劑,含有巴比妥及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099655 | 醫藥製劑,含有溴西泮(溴氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099664 | 醫藥製劑,含有勞拉西泮(樂耐平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099673 | 醫藥製劑,含有美達西泮(美達氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099682 | 醫藥製劑,含有甲丙氨酯(美普巴邁)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099691 | 醫藥製劑,含有硝西泮(耐妥眠)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099717 | 醫藥製劑,含有去甲西泮(原氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099726 | 醫藥製劑,含有去甲羥安定(歐沙氮平、去甲羥氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099735 | 醫藥製劑,含有噁唑他(㗁甲唑侖)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099744 | 醫藥製劑,含有匹嗎啉(苯㗁唑啉)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099753 | 醫藥製劑,含有氯巴占(甲酮氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099762 | 醫藥製劑,含有氯硝西泮(可那氮平、氯硝氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099771 | 醫藥製劑,含有氯拉䓬酸(氯氮平酸鹽)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099780 | 醫藥製劑,含有氯噁唑他(氯㗁唑侖)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099799 | 醫藥製劑,含有安定(二氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099815 | 醫藥製劑,含有氟安定(氟路洛)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099824 | 醫藥製劑,含有普拉西泮(環丙氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099833 | 醫藥製劑,含有莫待芬寧及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099842 | 醫藥製劑,含有美妥芬諾及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099851 | 醫藥製劑,含有氯苄雷司及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099860 | 醫藥製劑,含有離胺右旋安非他命及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099904 | 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者 | 0% | 0% | 10% |
- · 營業稅=(完稅價格+進口稅+貨物稅或菸酒稅+菸品健康福利捐)× 5%,依營業稅法第 41 條由海關代徵。
- · 推廣貿易服務費:按完稅價格 0.04% 計收(設有最低門檻)。
- · 貨物稅:僅對貨物稅條例所列項目課徵,例如電器、車輛、油氣、水泥、飲料、平板玻璃與橡膠輪胎;計算基礎為完稅價格加進口稅。
- · 菸酒稅:捲菸每千支新臺幣 1,590 元、啤酒每公升 26 元、蒸餾酒每公升每度 2.5 元等;菸品另加健康福利捐每千支 1,000 元。
- · 特種貨物及勞務稅:對逾一定金額的小客車、飛機、遊艇及高價貨物課徵 10%。
稅金概算
- 採用稅率
- 0%
- 完稅價格
- —
- 關稅
- —
- 營業稅
- —
- 預估總額
- —
此為概算。實際金額會因完稅價格核定、稅則歸列與原產地認定而不同。
資料日期: 2026-07-29
4輸入規定
- 503進口人用藥品(包括製劑、原料藥、助診藥類及人用生物製劑):應檢附(一)藥商許可執照影本及衛生福利部核發之(輸入)藥品許可證影本,或(二)衛生福利部核發之同意文件。
Importation of drugs (including pharmaceutical products, active pharmaceutical ingredients, diagnostics and biological products) for human use requires either of the following: (1) a photocopy of the drug (import) license issued by the Ministry of Health and Welfare together with a photocopy of the license of the pharmaceutical firm; or (2) an approval issued by the Ministry of Health and Welfa…
- 504一、進口人用醫療器材應依下列規定辦理:(一)應檢附衛生福利部核發之醫療器材許可證影本或同意文件,並應申報填列醫療器材許可證號碼(十四碼)。(二)如屬危險性醫療儀器,除應檢附衛生福利部核發之醫療器材許可證影本,及申報填列醫療器材許可證號碼(十四碼)外,並須檢附衛生福利部核准醫療機構購置之同意文件。二、非供人用者免依上述規定辦理。
1. Importation of medical devices for human use must be handled according to the following regulations: (1) A photocopy of the medical devices pre-marketing license or an approval document issued by the Ministry of Health and Welfare should be submitted. In addition, the number of the pre-marketing license (consisting of 14 letters and digits) must be declared and listed in the import declaration…
- 505進口中藥藥品(藥品許可證處方內容以中文標示者)應檢附(一)藥商許可執照影本及衛生福利部核發之(輸入)藥品許可證影本,或(二)衛生福利部中醫藥司核發之同意文件。
Importation of Chinese medicines (with the content of the formula of the drug written in Chinese on the import license) requires either of the following: (1) a photocopy of the drug (import) license issued by the Ministry of Health and Welfare together with a photocopy of the license of the pharmaceutical firm; or (2) an approval issued by the Department of Chinese Medicine and Pharmacy, Ministry…
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 802(一)進口人用藥品,應依503規定辦理(二)進口動物用藥品,應依406規定辦理。(三)進口非屬上述項目者,應註明「本貨品非屬人用藥品、動物用藥品」字樣,免依上述規定辦理。
(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is "not to be used as human use and veterinary medicines" is required.
- 802(一)進口人用藥品,應依503規定辦理(二)進口動物用藥品,應依406規定辦理。(三)進口非屬上述項目者,應註明「本貨品非屬人用藥品、動物用藥品」字樣,免依上述規定辦理。
(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is "not to be used as human use and veterinary medicines" is required.
- 802(一)進口人用藥品,應依503規定辦理(二)進口動物用藥品,應依406規定辦理。(三)進口非屬上述項目者,應註明「本貨品非屬人用藥品、動物用藥品」字樣,免依上述規定辦理。
(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is "not to be used as human use and veterinary medicines" is required.
- 802(一)進口人用藥品,應依503規定辦理(二)進口動物用藥品,應依406規定辦理。(三)進口非屬上述項目者,應註明「本貨品非屬人用藥品、動物用藥品」字樣,免依上述規定辦理。
(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is "not to be used as human use and veterinary medicines" is required.
- 802(一)進口人用藥品,應依503規定辦理(二)進口動物用藥品,應依406規定辦理。(三)進口非屬上述項目者,應註明「本貨品非屬人用藥品、動物用藥品」字樣,免依上述規定辦理。
(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is "not to be used as human use and veterinary medicines" is required.
- 802(一)進口人用藥品,應依503規定辦理(二)進口動物用藥品,應依406規定辦理。(三)進口非屬上述項目者,應註明「本貨品非屬人用藥品、動物用藥品」字樣,免依上述規定辦理。
(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is "not to be used as human use and veterinary medicines" is required.
- 802(一)進口人用藥品,應依503規定辦理(二)進口動物用藥品,應依406規定辦理。(三)進口非屬上述項目者,應註明「本貨品非屬人用藥品、動物用藥品」字樣,免依上述規定辦理。
(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is "not to be used as human use and veterinary medicines" is required.
- 804(一)進口人用藥品,應依503規定辦理(二)進口人用醫療器材,應依504規定辦理。(三)進口動物用藥品,應依406規定辦理。(四)進口非屬上述項目者,應註明「本貨品非屬人用藥品、人用醫療器材、動物用藥品」字樣,免依上述規定辦理。
(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of medical devices for human use is governed by the regulation of"504" (3)Importation of veterinary medicines is governed by the regulation of "406".(4)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is…
- 804(一)進口人用藥品,應依503規定辦理(二)進口人用醫療器材,應依504規定辦理。(三)進口動物用藥品,應依406規定辦理。(四)進口非屬上述項目者,應註明「本貨品非屬人用藥品、人用醫療器材、動物用藥品」字樣,免依上述規定辦理。
(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of medical devices for human use is governed by the regulation of"504" (3)Importation of veterinary medicines is governed by the regulation of "406".(4)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is…
- 804(一)進口人用藥品,應依503規定辦理(二)進口人用醫療器材,應依504規定辦理。(三)進口動物用藥品,應依406規定辦理。(四)進口非屬上述項目者,應註明「本貨品非屬人用藥品、人用醫療器材、動物用藥品」字樣,免依上述規定辦理。
(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of medical devices for human use is governed by the regulation of"504" (3)Importation of veterinary medicines is governed by the regulation of "406".(4)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is…
- 814(一)進口人用中藥藥品,應依505規定辦理。(二)進口動物用中藥藥品,應依406規定辦理。(三)進口本項貨品未取得上開主管機關輸入許可文件者,不准進口。
(1) Importation of traditional chinese drugs for human use is governed by the regulation of "505". (2) Importation of veterinary chinese medicines is governed by the regulation of "406".(3) For importing good under this item without import approval document from the competent authority, is not allowed to be imported.
- MP1(一)大陸物品有條件准許輸入,應符合「大陸物品有條件准許輸入項目、輸入管理法規彙總表」之規定。(二)「大陸物品有條件准許輸入項目、輸入管理法規彙總表」內列有特別規定「MXX」代號者,應向國際貿易署辦理輸入許可證;未列有特別規定「MXX」代號者,依一般簽證規定辦理。
(1) Importation of Mainland China products in this category is conditionally permitted. The importation should conform to the regulations of "Consolidated List of Conditional Import Items of Mainland China Origin and Regulations Governing Import of Mainland China Origin Commodities".(2) Importation of items on the "Consolidated List of Conditional Import Items of Mainland China Origin and Regulat…
- MW0大陸物品不准輸入。
Importation of Mainland China products is prohibited.
- MW0大陸物品不准輸入。
Importation of Mainland China products is prohibited.
- MW0大陸物品不准輸入。
Importation of Mainland China products is prohibited.
- MW0大陸物品不准輸入。
Importation of Mainland China products is prohibited.
- MW0大陸物品不准輸入。
Importation of Mainland China products is prohibited.
- MW0大陸物品不准輸入。
Importation of Mainland China products is prohibited.
- MW0大陸物品不准輸入。
Importation of Mainland China products is prohibited.
- MW0大陸物品不准輸入。
Importation of Mainland China products is prohibited.
- MW0大陸物品不准輸入。
Importation of Mainland China products is prohibited.
相關機關
- 財政部關務署進口通關、稅則分類、關稅核估與代徵營業稅、貨物稅web.customs.gov.tw
- 關港貿單一窗口進出口報單、輸入規定查詢與稅費繳納的電子平臺portal.sw.nat.gov.tw
- 經濟部國際貿易署貨品輸出入規定、輸入許可證、大陸物品輸入管理(MW0/MP1)trade.gov.tw
- 經濟部標準檢驗局(BSMI)應施檢驗商品的報驗、驗證與商品安全標示bsmi.gov.tw
- 衛生福利部食品藥物管理署(TFDA)輸入食品邊境查驗、化粧品產品登錄與產品資訊檔案fda.gov.tw
- 農業部動植物防疫檢疫署動植物及其產品的輸入檢疫aphia.gov.tw
資料日期: 2026-08-27
5文件
中國 出口文件
- 出口貨物報關單
- 核發單位:
- 發貨人或受委託的報關企業,經中國國際貿易單一窗口申報
- 時點:
- 貨物裝運前
跨境電商出口使用 9610、9710、9810 等專門監管方式代碼。
官方頁面 - 商業發票與裝箱單
- 核發單位:
- 出口企業
- 時點:
- 報關時
載明品名、規格、數量、單價、貿易條件與原產地,亦為輸入國海關核估的依據。
官方頁面 - 提單(B/L)或空運提單(AWB)
- 核發單位:
- 運送人或承攬業者
- 時點:
- 裝運後簽發
供結匯與買方提貨,亦為辦理出口退稅的憑證之一。
官方頁面 - 出口許可證/兩用物項和技術出口許可證
- 核發單位:
- 商務部及其授權發證機構
- 時點:
- 屬管制或許可證管理商品者,報關前取得
兩用物項須查核最終使用者與最終用途;部分物項另有專門的管制清單。
官方頁面 - 出境貨物檢驗檢疫單證
- 核發單位:
- 海關
- 時點:
- 屬法定檢驗目錄商品者,報關前完成
包括抽樣檢驗、檢疫處理與相應證書。
官方頁面 - 原產地證書
- 核發單位:
- 海關或中國國際貿易促進委員會(CCPIT)
- 時點:
- 買方於輸入國主張優惠稅率時
包括 RCEP、中韓自貿協定原產地證書、輸往臺灣的 ECFA 原產地證明書,以及一般原產地證書(CO)。
官方頁面 - 報關委託協議
- 核發單位:
- 出口企業與報關企業
- 時點:
- 委託代理報關前
明確雙方的申報責任與授權範圍。
官方頁面 - 出口退(免)稅申報資料
- 核發單位:
- 出口企業
- 時點:
- 貨物報關出口並收匯後
包括增值稅專用發票或進貨憑證、出口貨物報關單資訊與收匯憑證。
官方頁面 - 訂艙單/裝貨單
- 核發單位:
- 運送人或承攬業者
- 時點:
- 訂艙後取得
作為貨物進入海關監管作業場所與裝運的依據。
官方頁面
臺灣 進口文件
- 進口報單
- 核發單位:
- 報關業者或進口人,經關港貿單一窗口傳輸
- 時點:
- 自運輸工具進口日之翌日起 15 日內
低價快遞貨物得改以簡易申報單(X1 至 X3)申報;涉及輸入規定、退稅、配額、特別關稅或特種貨物稅者,須以一般進口報單申報。
官方頁面 - 小提單(提貨單,D/O)
- 核發單位:
- 運送人或承攬業者
- 時點:
- 貨物抵達後換領
憑以自貨櫃集散站或倉庫提領貨物。
官方頁面 - 商業發票
- 核發單位:
- 出口人
- 時點:
- 報關時
核估完稅價格的主要依據,應載明品名、數量、單價、貿易條件與原產地。
官方頁面 - 裝箱單
- 核發單位:
- 出口人
- 時點:
- 報關時
查驗(C3)時作為核對資料。
官方頁面 - 提單(B/L)或空運提單(AWB)
- 核發單位:
- 運送人
- 時點:
- 裝運時簽發
與艙單核對,並作為換領小提單的依據。
官方頁面 - 產地證明書
- 核發單位:
- 出口國簽發機構
- 時點:
- 適用優惠稅率或輸入規定要求時
自中國大陸輸入早收清單貨品欲適用 ECFA 優惠者,須檢附 ECFA 原產地證明書。
官方頁面 - 輸入許可證
- 核發單位:
- 經濟部國際貿易署或其他主管機關
- 時點:
- 貨品分類表「輸入規定」欄有相應代號時
無代號者多為免證進口;MW0、MP1 等代號涉及大陸物品的輸入管理。
官方頁面 - 委任書
- 核發單位:
- 進口人(納稅義務人)
- 時點:
- 委任報關業者前
報關業者據以代辦報關、繳稅與提領。
官方頁面 - 檢驗與查驗文件
- 核發單位:
- 經濟部標準檢驗局(BSMI)、衛生福利部食品藥物管理署(TFDA)
- 時點:
- 報關同時或報關前
應施檢驗商品的報驗合格證明;輸入食品的查驗申請;化粧品的產品登錄與產品資訊檔案(PIF)。
官方頁面
6流程
- 預報貨物資訊與進儲運送人傳輸艙單,貨物卸船後進儲貨櫃集散站、碼頭或保稅倉庫。
- 換領小提單與備妥文件向運送人或承攬業者換領小提單,備妥發票、裝箱單、產地證明與必要的輸入許可證。
- 遞送進口報單由報關業者或進口人經關港貿單一窗口遞送進口報單,申報期限為自運輸工具進口日之翌日起 15 日內。
- 通關方式篩選系統篩選為 C1(免審免驗)、C2(文件審核)或 C3(貨物查驗,分人工查驗 C3M 與儀器查驗 C3X)。屬應施檢驗或查驗商品者,須先取得主管機關結果。
- 繳納稅費繳納關稅、營業稅、貨物稅(如有)與推廣貿易服務費,可線上繳納,亦可依規定申請先放後稅。
- 放行與提領取得放行通知後自集散站提領貨物。事後仍有更正、退稅與海關事後稽核等程序。
- 艙單與進儲航空公司傳輸艙單,貨物進儲航空貨物集散站。
- 備妥文件與遞送報單備妥文件後經關港貿單一窗口遞送進口報單,同樣適用 15 日申報期限。
- 通關方式與查驗依 C1/C2/C3 分流;屬 BSMI 或 TFDA 管理商品者,須完成報驗或查驗程序。
- 繳稅繳納關稅、營業稅與相關規費。
- 放行提貨自航空貨物集散站提領貨物。
- 快遞貨物分類依完稅價格分為 X1(進口快遞文件)、X2(2,000 元以下低價免稅)、X3(2,001 至 50,000 元低價應稅)與 X4(逾 50,000 元高價貨物)。
- 簡易申報或一般報單X1 至 X3 得以簡易申報單申報;X4 及涉及輸入規定、退稅、配額、特別關稅或特種貨物稅者,須以一般進口報單申報。
- 免稅與頻繁進口判斷完稅價格 2,000 元以下者免稅,但同一納稅義務人半年度內逾 6 次者列為頻繁進口,其後不再適用免稅。菸、酒與關稅配額農產品不適用。
- 繳稅應稅者由快遞業者代為繳納後向收貨人收取,或由收貨人自行繳納。
- 應施檢驗商品跨境網購的電器等應施檢驗商品,仍須依規定報驗或申請免驗,未符規定者不予放行並可能受罰。
- 入境申報旅客攜帶行李物品入境時,應稅或應申報物品走紅線檯,並填具申報單。
- 免稅額度成年旅客自用行李物品完稅價格總值在新臺幣 20,000 元以下者免稅,酒類與菸品另有數量限制。
- 商業性貨物非自用的商業性貨物即使隨身攜帶,仍須依一般進口程序報關,並符合輸入規定與檢驗要求。
- 繳稅逾免稅額度部分於入境時由海關核估課稅並當場繳納。
顯示 中國 出口端流程
- 資格與前置查詢完成海關進出口貨物收發貨人備案與出口退稅相關備案;查詢商品編碼對應的監管條件與出口退稅率,判斷是否需要許可證或法定檢驗。
- 訂艙、備貨與辦證訂艙並取得裝貨單,完成包裝與嘜頭;辦理出口許可證、兩用物項許可與出境檢驗檢疫。
- 申報透過單一窗口提交出口貨物報關單,裝運前完成申報;可自行申報或委託報關企業。
- 查驗與檢驗檢疫配合海關查驗,屬法定檢驗商品者完成檢驗檢疫程序。
- 放行與裝船離境海關放行後裝船離境,取得提單與報關單結關資訊。
- 收匯與退稅辦理收匯,並依規定申報出口退(免)稅;單證與資訊須相互匹配。
7難度
分數: 0.87
這是依公開資料計算的訊號,並非諮詢意見。
判定理由
- regime[TFDA] Medicines need a pharmaceutical-firm licence and a per-product marketing licence; even personal-use import is quantity-capped.(en)fda.gov.tw2026-09-07
- requirement6 destination import requirement(s) found: For importation of controlled drugs (including narcotics dru, (1) Importation of medicines for human use is governed by th, Importation of Chinese medicines (with the content of the fo(en)portal.sw.nat.gov.tw2026-09-07
- ambiguityClassification is contested — rulings for this HS6 scatter across several subheadings and are often decided against neighbouring codes(en)web.customs.gov.tw2026-09-07
組成
| 進口規定 | 0.89 | For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an ap portal.sw.nat.gov.tw(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of co portal.sw.nat.gov.twImportation of Chinese medicines (with the content of the formula of the drug written in Chinese on the import license) requires either of the following: (1) a photocopy of the dru portal.sw.nat.gov.tw |
|---|---|---|
| 歸列模糊度 | 0.56 | TW 결정례 17건 · 하위 세번 2종으로 분산 web.customs.gov.twUS CROSS 1057건 중 복수 세번 결정 비율 21% · 같은 사건에서 함께 검토된 다른 HS6 66개 rulings.cbp.gov |
| 管制制度 | 1.00 | 藥事法 — 藥商許可執照 + 藥品許可證 fda.gov.tw |
資料日期: 2026-09-07
8案例
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者恢甲清覆甲液-全日型加強配方(未滅菌) EXCILOR FORTE-nail solution(non-sterile)核定號列: 30049099904日期: 2021
- 其他中藥製劑枳椇人參茶(Gan-Pyun-Han-Nal) / 液體茶 / 100ML /瓶核定號列: 30049069009日期: 2018
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者Hiruscar Silicone Pro(non-sterile) 喜療疤 疤痕護理矽凝膠(未滅菌)核定號列: 30049099904日期: 2018
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者貽貝粘蛋白創面修復敷料 型號、規格:0.5mg/mL×0.2mL、0.5mg/mL×0.5mL、0.5mg/mL×1mL、0.5mg/mL×3mL、0.5mg/mL×5mL 0.5mg/mL×10mL、0.5mg/mL×15mL、0.5mg/mL×20mL、1.5mg/mL×0.2mL、1.5mg/mL×0.5mL 1.5mg/mL×3mL、……、1.5mg/mL×20mL等(詳附件)核定號列: 30049099904日期: 2018
- 其他中藥製劑云南彝葯排毒眼罩核定號列: 30049069009日期: 2018
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者恢甲清覆甲筆(未滅菌) EXCILOR Nail Pen(non-sterile)核定號列: 30049099904日期: 2017
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者恢甲清覆甲液(未滅菌) EXCILOR Nail Solution(non-sterile)核定號列: 30049099904日期: 2017
- 其他中藥製劑黃金紅蔘精/液體(茶)食品/Net wt. 250g/真空玻璃瓶核定號列: 30049069009日期: 2017
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者品名:通用名:骨修復材料 商標名:骨優導 / 型號規格:1mg rhBMP-2/Bottle核定號列: 30049099904日期: 2017
- 其他中藥製劑韓國護肝寶 HD-1 Premium核定號列: 30049069009日期: 2017
- 其他中藥製劑晋山之韵/台灣商品名:沛之臨 益甘飲核定號列: 30049069009日期: 2017
- 其他中藥製劑慶珍丸核定號列: 30049069009日期: 2016
- 其他中藥製劑紅蔘鹿茸元氣精核定號列: 30049069009日期: 2016
- 其他中藥製劑五加皮精核定號列: 30049069009日期: 2016
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者ESOXX ONE核定號列: 30049099904日期: 2016
顯示其他國家案例 (30)
- KRㅇ 재우스오라쿠고에이취플라스타(살리실산); OLAKUKO - H;
- KRMedicaments; 재우스오라쿠고에이취플라스타(살리실산)
- KRPOSS
- KRS1
- KRBOSS
- KRMedicaments; DIABEX XR 500mg
- KRINVISIBLE MASK
- KRMedicaments, packings for retail sale
- KRMedicament; Mentho Pas Lotion
- KRMedicaments, anti-cancer preparation TEPADINA, Thiotepa
- KRMedicaments; 인애백년보건고; PR.CHNA
- KRMedicaments; FD; MEXICO
- KRMedicaments; Turbocaina; MEXICO
- KRMedicaments; Nutriband Slimline patch; U.S.A
- KRCollagen Preparation; COLTRIX CartiRegen
- USThe tariff classification of Pantoprazole Sodium Tablets in dosage form, from India
- USThe tariff classification of Tadalafil Tablets in dosage form, from India
- USThe tariff classification of Nintedanib Capsules in dosage form, from India
- USThe tariff classification of Brivaracetam Oral Solution in dosage form, from India
- USThe tariff classification of Colestipol Hydrochloride Tablets in dosage form, from Taiwan
來源: 財政部 — 海外網購雖容易 頻繁進口要留意 · 財政部關務署 — 海關如何課徵進口貨物營業稅? · 財政部關務署 — 進口貨物應繳之稅費有那些? · 財政部關務署 — 大陸物品准許輸入項目為何? · 財政部關務署臺北關 — 進口快遞貨物簡易申報應注意及配合事項 · 財政部主管法規共用系統 — 空運快遞貨物簡易申報通關作業規定 · 經濟部國際貿易署 — 大陸物品輸入特別規定查詢 · 衛生福利部食品藥物管理署 — 化粧品產品登錄專區 · 中國國際貿易單一窗口 · 中國海關總署網上辦事服務 — 辦事指南(企業備案與申報) · 中國海關總署 · 中國商務部 · 中國國家稅務總局 — 出口退(免)稅 · 中國國際貿易促進委員會
身分: 承攬業者 — 會改變頁面強調的區塊